| Revenues | |
| Net product revenue (Note 8) | |
| Royalties | |
| Revenues | |
| Costs and expenses | |
| Cost of sales | |
| Research and development | 2.86M |
| Selling, general and administrative | 3.14M |
| Depreciation | |
| Costs and expenses | 6.02M |
| Operating loss | -6.02M |
| Investment and other income | |
| Net foreign exchange gains (losses) | -105K |
| Interest income | |
| Fair value change in contingent consideration | |
| Other gains | |
| Investment and other income | -34K |
| Loss before income taxes | |
| (Provision for) recovery of income taxes (Note 10) | 115K |
| Net (loss) income | |
| Basic and diluted net (loss) income per common share | -0.11 |
| Basic | |
| Diluted | |